At 7.1% CAGR, the North America Bovine Diagnostics Market is projected to be worth US$ 768.88 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the North America bovine diagnostics market was valued at US$ 443.82 million in 2022 and is expected to reach US$ 768.88 million by 2030, registering a CAGR of 7.1% from 2022 to 2030. High prevalence and economic impact of bovine mastitis and integration of data analytics and artificial intelligence (AI) are among the critical factors attributed to the North America bovine diagnostics market expansion.       

The integration of data analytics and AI in bovine diagnostics is revolutionizing the cattle industry. AI algorithms, coupled with extensive data analytics, enable sophisticated analysis of large datasets obtained from various sources in cattle farming. These technologies facilitate predictive modeling, disease trend analysis, and identification of health patterns, offering valuable insights into herd health.

Machine learning algorithms enable processing vast amounts of information, such as genetic data, historical health records, and environmental factors, to predict disease outbreaks, detect anomalies, and recommend optimal treatment strategies. Moreover, AI-driven diagnostic tools continuously learn and refine their accuracy, enhancing their ability to predict and prevent diseases in cattle populations.

By harnessing the power of AI and data analytics, veterinarians and livestock managers gain a deeper understanding of cattle health trends, enabling proactive measures to maintain herd health, improve breeding programs, and optimize overall farm productivity while ensuring animal welfare.

On the contrary, lack of skilled professionals in veterinary research hampers the North America bovine diagnostics market.

Based on product, the North America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held 47.0% share of North America bovine diagnostics market in 2022, amassing US$ 208.58 million. It is projected to garner US$ 384.44 million by 2030 to expand at 7.9% CAGR during 2022–2030.

Based on disease type, the North America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held 34.9% share of North America bovine diagnostics market in 2022, amassing US$ 154.90 million. It is projected to garner US$ 287.42 million by 2030 to expand at 8.0% CAGR during 2022–2030.

Based on end user, the North America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held 52.5% share of North America bovine diagnostics market in 2022, amassing US$ 233.02 million. It is projected to garner US$ 427.55 million by 2030 to expand at 7.9% CAGR during 2022–2030.

Based on country, the North America bovine diagnostics market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.8% share of North America bovine diagnostics market in 2022. It was assessed at US$ 371.84 million in 2022 and is likely to hit US$ 662.47 million by 2030, exhibiting a CAGR of 7.5% during 2022–2030.

Key players operating in the North America bovine diagnostics market are bioMerieux SA, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc, among others.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com